Yiyang Dai
Yiwu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Biglycan deficiency alleviates intestinal fibrosis through BMP-7-mediated Smad1/5/8 signaling.
Journal: Journal of Crohn's & colitis
Published: April 18, 2025
The Potential Role and Effective Components of Sanyeqing as the Potential Therapeutic Candidates for IBD and CRC.
Journal: OncoTargets and therapy
Published: January 27, 2025
Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2/GPX4 signal pathway and improving intestinal barrier.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: July 27, 2023
Effect of Premedication With Pronase Before Upper Gastrointestinal Endoscopy: A Multicenter Prospective Randomized Controlled Study.
Journal: Journal of clinical gastroenterology
Published: March 09, 2022
DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: November 19, 2020
Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe3+ as a novel theranostic agent for T1/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer.
Journal: Bioactive materials
Published: June 30, 2020
Fucoidan-based micelles as P-selectin targeted carriers for synergistic treatment of acute kidney injury.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: May 28, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026